These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11156553)

  • 41. Anxiolytic-like effect of Carvacrol (5-isopropyl-2-methylphenol) in mice: involvement with GABAergic transmission.
    Melo FH; Venâncio ET; de Sousa DP; de França Fonteles MM; de Vasconcelos SM; Viana GS; de Sousa FC
    Fundam Clin Pharmacol; 2010 Aug; 24(4):437-43. PubMed ID: 19909350
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis and in vivo evaluation of 3-substituted gababutins.
    Blakemore DC; Bryans JS; Carnell P; Chessum NE; Field MJ; Kinsella N; Kinsora JK; Osborne SA; Williams SC
    Bioorg Med Chem Lett; 2010 Jan; 20(1):362-5. PubMed ID: 19897364
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of anxiolytic effect and withdrawal anxiety in chronic intermittent diazepam treatment in rats.
    Açikmeşe B; Haznedar S; Hatipoğlu I; Enginar N
    Behav Pharmacol; 2012 Apr; 23(2):215-9. PubMed ID: 22327020
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Kaempferol from the leaves of Apocynum venetum possesses anxiolytic activities in the elevated plus maze test in mice.
    Grundmann O; Nakajima J; Kamata K; Seo S; Butterweck V
    Phytomedicine; 2009 Apr; 16(4):295-302. PubMed ID: 19303276
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of anxiolytic drugs on some behavioral consequences in olfactory bulbectomized rats.
    Wierońska JM; Papp M; Pilc A
    Pol J Pharmacol; 2001; 53(5):517-25. PubMed ID: 11990071
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 5-ethoxymethyl-7-fluoro-3-oxo-1,2,3,5-tetrahydrobenzo[4,5]imidazo[1,2a]pyridine-4-N-(2-fluorophenyl)carboxamide (RWJ-51204), a new nonbenzodiazepine anxiolytic.
    Dubinsky B; Vaidya AH; Rosenthal DI; Hochman C; Crooke JJ; DeLuca S; DeVine A; Cheo-Isaacs CT; Carter AR; Jordan AD; Reitz AB; Shank RP
    J Pharmacol Exp Ther; 2002 Nov; 303(2):777-90. PubMed ID: 12388665
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of ventral hippocampal GABA(A) and NMDA receptors in the anxiolytic effect of carbamazepine in rats using the elevated plus maze test.
    Rezvanfard M; Zarrindast MR; Bina P
    Pharmacology; 2009; 84(6):356-66. PubMed ID: 19907194
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anxiolytic activity of endogenous nootropic dipeptide cycloprolylglycine in elevated plus-maze test.
    Gudasheva TA; Konstantinopol'skii MA; Ostrovskaya RU; Seredenin SB
    Bull Exp Biol Med; 2001 May; 131(5):464-6. PubMed ID: 11550054
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pregabalin: its pharmacology and use in pain management.
    Gajraj NM
    Anesth Analg; 2007 Dec; 105(6):1805-15. PubMed ID: 18042886
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pregabalin in clinical psychiatry and addiction: pros and cons.
    Martinotti G
    Expert Opin Investig Drugs; 2012 Sep; 21(9):1243-5. PubMed ID: 22725618
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Neurochemical characteristics of the ventromedial hypothalamus and anti-aversive effects of anxiolytic agents in various anxiety models].
    Talalaenko AN; Pankrat'ev DV; Goncharenko NV
    Ross Fiziol Zh Im I M Sechenova; 2001 Sep; 87(9):1217-26. PubMed ID: 11763535
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The diverse therapeutic actions of pregabalin: is a single mechanism responsible for several pharmacological activities?
    Stahl SM; Porreca F; Taylor CP; Cheung R; Thorpe AJ; Clair A
    Trends Pharmacol Sci; 2013 Jun; 34(6):332-9. PubMed ID: 23642658
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of anxiolytic treatment on potentiated startle during aversive image anticipation.
    Acheson DT; Stein MB; Paulus MP; Ravindran L; Simmons AN; Lohr JB; Risbrough VB
    Hum Psychopharmacol; 2012 Jul; 27(4):419-27. PubMed ID: 22782542
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis, characterization and in vitro pharmacology of novel pregabalin derivatives.
    Horvat S; Hamersak Z; Stipetić I; Jolas T
    Eur J Med Chem; 2010 Apr; 45(4):1447-52. PubMed ID: 20079559
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pregabalin suppresses calcium-mediated proteolysis and improves stroke outcome.
    Yoon JS; Lee JH; Son TG; Mughal MR; Greig NH; Mattson MP
    Neurobiol Dis; 2011 Mar; 41(3):624-9. PubMed ID: 21111818
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Pregabalin as a probable cause of thrombocytopenia: presentation of two clinical cases and review of literature].
    Reyes-Molón L; Gallego-Deike L
    Actas Esp Psiquiatr; 2014; 42(1):39-40. PubMed ID: 24504992
    [No Abstract]   [Full Text] [Related]  

  • 57. Chronic pregabalin treatment reduced anxiety, and acute pregabalin treatment increased depression-like behaviors in rats.
    Çalışkan H; Akat F; Dursun AD; Zaloğlu N
    BMC Pharmacol Toxicol; 2024 Oct; 25(1):72. PubMed ID: 39354569
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enhancing a Sphaerobacter thermophilus ω-transaminase for kinetic resolution of β- and γ-amino acids.
    Wegner U; Matthes F; von Wirén N; Lemke I; Bode R; Vorbrodt HM; Rauter M; Kunze G
    AMB Express; 2023 Oct; 13(1):117. PubMed ID: 37864072
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Frequency matters: how changes in hippocampal theta frequency can influence temporal coding, anxiety-reduction, and memory.
    Hines M; Poulter S; Douchamps V; Pibiri F; McGregor A; Lever C
    Front Syst Neurosci; 2022; 16():998116. PubMed ID: 36817946
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pregabalin Alleviates Anxiety and Fear in Cats during Transportation and Veterinary Visits-A Clinical Field Study.
    Lamminen T; Korpivaara M; Aspegrén J; Palestrini C; Overall KL
    Animals (Basel); 2023 Jan; 13(3):. PubMed ID: 36766260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.